A new tariff for marketing authorisations, annual fees and other licence fees for medicinal products and other related products, collected by the Icelandic Medicines Agency came into effect on 8th of April 2026.
The Minister of Health, upon receiving proposals from the Icelandic Medicines Agency, establishes the fee schedule for services provided, supervision, and tasks entrusted to the agency in accordance with the Medicinal Products Act No. 100/2020.
In the event of any discrepancy between the Icelandic and English versions of the tariff, the Icelandic version shall prevail.